0001470930-16-000002.txt : 20160921
0001470930-16-000002.hdr.sgml : 20160921
20160921131232
ACCESSION NUMBER: 0001470930-16-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20160921
DATE AS OF CHANGE: 20160921
EFFECTIVENESS DATE: 20160921
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOXINESS PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001470930
IRS NUMBER: 262157552
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-271024
FILM NUMBER: 161895354
BUSINESS ADDRESS:
STREET 1: 750 ALFRED NOBEL DRIVE SUITE 106
CITY: HERCULES
STATE: CA
ZIP: 94547
BUSINESS PHONE: 510 724 1548
MAIL ADDRESS:
STREET 1: 750 ALFRED NOBEL DRIVE SUITE 106
CITY: HERCULES
STATE: CA
ZIP: 94547
D
1
primary_doc.xml
X0707
D
LIVE
0001470930
BIOXINESS PHARMACEUTICALS, INC.
750 ALFRED NOBEL DRIVE SUITE 106
HERCULES
CA
CALIFORNIA
94547
510 724 1548
CALIFORNIA
Bioxiness Health Specialties International
None
Corporation
true
Mansour
Bassiri
c/o Bioxiness Pharmaceuticals, Inc.
750 Alfred Nobel Dr. Suite 106
Hercules
CA
CALIFORNIA
94547
Executive Officer
Director
Promoter
Susan
Froshauer
c/o Bioxiness Pharmaceuticals, Inc.
750 Alfred Nobel Dr. Suite 106
Hercules
CA
CALIFORNIA
94547
Director
Matthew
Kerby
c/o Bioxiness Pharmaceuticals, Inc.
750 Alfred Nobel Dr. Suite 106
Hercules
CA
CALIFORNIA
94547
Director
Constance
McKee
c/o Bioxiness Pharmaceuticals, Inc.
750 Alfred Nobel Dr. Suite 106
Hercules
CA
CALIFORNIA
94547
Director
Clinton
Severson
c/o Bioxiness Pharmaceuticals, Inc.
750 Alfred Nobel Dr. Suite 106
Hercules
CA
CALIFORNIA
94547
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2016-09-06
false
true
true
Conversion of convertible notes into equity
false
0
1000000
502000
498000
true
18
29
0
0
2000
true
false
BIOXINESS PHARMACEUTICALS, INC.
/s/Mansour Bassiri
Mansour Bassiri
Chief Executive Officer
2016-09-21